223 related articles for article (PubMed ID: 35204236)
1. Cyanobacteria and Algae-Derived Bioactive Metabolites as Antiviral Agents: Evidence, Mode of Action, and Scope for Further Expansion; A Comprehensive Review in Light of the SARS-CoV-2 Outbreak.
Pradhan B; Nayak R; Patra S; Bhuyan PP; Dash SR; Ki JS; Adhikary SP; Ragusa A; Jena M
Antioxidants (Basel); 2022 Feb; 11(2):. PubMed ID: 35204236
[TBL] [Abstract][Full Text] [Related]
2. Microbial Metabolites: The Emerging Hotspot of Antiviral Compounds as Potential Candidates to Avert Viral Pandemic Alike COVID-19.
Raihan T; Rabbee MF; Roy P; Choudhury S; Baek KH; Azad AK
Front Mol Biosci; 2021; 8():732256. PubMed ID: 34557521
[TBL] [Abstract][Full Text] [Related]
3. Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2.
Alam MA; Parra-Saldivar R; Bilal M; Afroze CA; Ahmed MN; Iqbal HMN; Xu J
Molecules; 2021 Apr; 26(8):. PubMed ID: 33917694
[TBL] [Abstract][Full Text] [Related]
4. Plants-Derived Biomolecules as Potent Antiviral Phytomedicines: New Insights on Ethnobotanical Evidences against Coronaviruses.
Siddiqui AJ; Danciu C; Ashraf SA; Moin A; Singh R; Alreshidi M; Patel M; Jahan S; Kumar S; Alkhinjar MIM; Badraoui R; Snoussi M; Adnan M
Plants (Basel); 2020 Sep; 9(9):. PubMed ID: 32967179
[TBL] [Abstract][Full Text] [Related]
5. Marine-Derived Bioactive Metabolites as a Potential Therapeutic Intervention in Managing Viral Diseases: Insights from the SARS-CoV-2 In Silico and Pre-Clinical Studies.
Okechukwu QN; Adepoju FO; Kanwugu ON; Adadi P; Serrano-Aroca Á; Uversky VN; Okpala COR
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543114
[TBL] [Abstract][Full Text] [Related]
6. Multifaceted role of natural sources for COVID-19 pandemic as marine drugs.
Rahman MM; Islam MR; Shohag S; Hossain ME; Shah M; Shuvo SK; Khan H; Chowdhury MAR; Bulbul IJ; Hossain MS; Sultana S; Ahmed M; Akhtar MF; Saleem A; Rahman MH
Environ Sci Pollut Res Int; 2022 Jul; 29(31):46527-46550. PubMed ID: 35507224
[TBL] [Abstract][Full Text] [Related]
7. Potential "biopeptidal" therapeutics for severe respiratory syndrome coronaviruses: a review of antiviral peptides, viral mechanisms, and prospective needs.
Ashaolu TJ; Nawaz A; Walayat N; Khalifa I
Appl Microbiol Biotechnol; 2021 May; 105(9):3457-3470. PubMed ID: 33876282
[TBL] [Abstract][Full Text] [Related]
8. Bioactive natural compounds against human coronaviruses: a review and perspective.
Xian Y; Zhang J; Bian Z; Zhou H; Zhang Z; Lin Z; Xu H
Acta Pharm Sin B; 2020 Jul; 10(7):1163-1174. PubMed ID: 32834947
[TBL] [Abstract][Full Text] [Related]
9. Potential Immunomodulatory Properties of Biologically Active Components of Spices Against SARS-CoV-2 and Pan β-Coronaviruses.
Sengupta S; Bhattacharyya D; Kasle G; Karmakar S; Sahu O; Ganguly A; Addya S; Das Sarma J
Front Cell Infect Microbiol; 2021; 11():729622. PubMed ID: 34513735
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
11. Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19.
Wijayasinghe YS; Bhansali P; Viola RE; Kamal MA; Poddar NK
Curr Pharm Des; 2021; 27(33):3526-3550. PubMed ID: 33213322
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
13. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
[TBL] [Abstract][Full Text] [Related]
14. Natural Products as Potential Leads Against Coronaviruses: Could They be Encouraging Structural Models Against SARS-CoV-2?
Orhan IE; Senol Deniz FS
Nat Prod Bioprospect; 2020 Aug; 10(4):171-186. PubMed ID: 32529545
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside Inhibitors of Coronaviruses.
Zenchenko AA; Drenichev MS; Mikhailov SN
Curr Med Chem; 2021; 28(26):5284-5310. PubMed ID: 33563148
[TBL] [Abstract][Full Text] [Related]
16. Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.
Huang T; Sun L; Kang D; Poongavanam V; Liu X; Zhan P; Menéndez-Arias L
Adv Exp Med Biol; 2021; 1322():219-260. PubMed ID: 34258743
[TBL] [Abstract][Full Text] [Related]
17. Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects.
Nagahawatta DP; Liyanage NM; Jayawardena TU; Jayawardhana HHACK; Jeong SH; Kwon HJ; Jeon YJ
Mar Life Sci Technol; 2024 May; 6(2):280-297. PubMed ID: 38827130
[TBL] [Abstract][Full Text] [Related]
18. Algal Metabolites Can Be an Immune Booster against COVID-19 Pandemic.
Kumar A; Singh RP; Kumar I; Yadav P; Singh SK; Kaushalendra ; Singh PK; Gupta RK; Singh SM; Kesawat MS; Saratale GD; Chung SM; Kumar M
Antioxidants (Basel); 2022 Feb; 11(3):. PubMed ID: 35326102
[TBL] [Abstract][Full Text] [Related]
19. Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis.
Reynolds D; Huesemann M; Edmundson S; Sims A; Hurst B; Cady S; Beirne N; Freeman J; Berger A; Gao S
Algal Res; 2021 Jul; 57():102331. PubMed ID: 34026476
[TBL] [Abstract][Full Text] [Related]
20. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
Gudadappanavar AM; Benni J
J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
